About the Annual General Meeting

The Annual General Meeting (AGM) is the company’s highest governing body. The Board of Directors is responsible for ensuring that the AGM functions as an effective and well‑organized forum for shareholder decision‑making.

Before the Annual General Meeting

The AGM is normally held before 1 June each year and never later than the statutory deadline of 30 June. The financial calendar is published through the Oslo Stock Exchange and on the company’s website.  The notice of meeting and relevant documentation will be made available at www.navamedic.com no later than 21 days prior to the AGM. These documents will include all information necessary for shareholders to make informed decisions on the matters up for consideration. In accordance with the company’s practice, the deadline for notifying attendance is no later than two days before the meeting. 

Participation

Shareholders must register for the AGM in writing, either by mail, e‑mail or online. Shareholders who are unable to attend are encouraged to appoint a proxy. A proxy form will be included with the AGM notice. The form will allow shareholders, as far as possible, to vote on each individual agenda item and each candidate up for election. A designated proxy will also be appointed to vote on behalf of shareholders who wish to authorize such representation.

Members of the Board will attend the AGM. The company’s auditor will be available upon the request of any shareholder. From the administration, the CEO and CFO will participate at a minimum.

Agenda and Proceedings

The AGM agenda is set by the Board in accordance with the Public Limited Companies Act and the company’s Articles of Association, paragraph 7.

After the formal AGM proceedings have concluded, the Group CEO will present an update on the Group’s status and ongoing activities.